Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study (Q31960153)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study |
scientific article |
Statements
1 reference
Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study (English)
1 reference
S P Ackland
1 reference
A Anton
1 reference
G P Breitbach
1 reference
E Colajori
1 reference
J M Tursi
1 reference
C Delfino
1 reference
A Efremidis
1 reference
A Ezzat
1 reference
A Fittipaldo
1 reference
K Kolaric
1 reference
M Lopez
1 reference
D Viaro
1 reference
HEPI 013 study group
1 reference
1 February 2001
1 reference
1 reference
Identifiers
1 reference